Leishmania sp. isolated from human cases of cutaneous leishmaniasis in Brazil characterized as Leishmania major-like

Acta Tropica

Volumn 112, Issue 3, 2009, Pages 239-248

  de Oliveira Silva, Soraia ^a   Wu, Angela Alvarenga ^a   Evans, David A ^b   Vieira, Leda Quercia ^a   Melo, Maria Norma ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Leishmania; Leishmania major; Leishmania major like; Tegumentary leishmaniasis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ANTIGEN; BACTERIUM; BIOLOGICAL ANALYSIS; DISEASE CONTROL; DISEASE TREATMENT; DNA; EPIDEMIOLOGY; GROWTH RATE; INSECT; MOLECULAR ANALYSIS; POLYMERASE CHAIN REACTION; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DNA FINGERPRINTING; ELECTROPHORETIC MOBILITY; FEMALE; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LEISHMANIA PANAMENSIS; MOUSE; NONHUMAN; PARASITE IDENTIFICATION; PARASITE ISOLATION; PARASITE VIRULENCE; PERITONEUM MACROPHAGE; POLYMERASE CHAIN REACTION; PROMASTIGOTE; RANDOM AMPLIFIED POLYMORPHIC DNA; SIMPLE SEQUENCE REPEAT; SKIN LEISHMANIASIS; STRAIN DIFFERENCE;

ANIMALS; BRAZIL; CELLS, CULTURED; CLUSTER ANALYSIS; CULTURE MEDIA; DNA FINGERPRINTING; DNA, PROTOZOAN; FEMALE; GENOTYPE; HUMANS; ISOENZYMES; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTOZOAN PROTEINS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SEVERITY OF ILLNESS INDEX; SKIN; VIRULENCE;

BRAZIL; SOUTH AMERICA;

HEXAPODA; LEISHMANIA CF. MAJOR; LEISHMANIA MAJOR; LEISHMANIA SP.; MURINAE; MUS;

EID: 71249093829     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.07.026     Document Type: Article

References (52)

1. Afonso L.C., and Scott P. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immunol. 61 (1993) 2952-2959
2. Al-Jawabreh A., Diezmann S., Muller M., Wirth T., Schnur L.F., Strelkova M.V., Kovalenko D.A., Razakov S.A., Schwenkenbecher J., Kuhls K., and Schonian G. Identification of geographically distributed sub-populations of Leishmania (Leishmania) major by microsatellite analysis. BMC. Evol. Biol. 8 (2008) 183
3. Anderson C.F., Mendez S., and Sacks D.L. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice. J. Immunol. 174 (2005) 2934-2941
4. Antunes C.M., Mayrink W., Magalhaes P.A., Costa C.A., Melo M.N., Dias M., Michalick M.S., Williams P., Lima A.O., and Vieira J.B. Controlled field trials of a vaccine against New World cutaneous leishmaniasis. Int. J. Epidemiol. 15 (1986) 572-580
5. Bañuls A.L., Hide M., and Tibayrenc M. Evolutionary genetics and molecular diagnosis of Leishmania species. Trans. R. Soc. Trop. Med. Hyg. 96 Suppl 1 (2002) S9-S13
6. Barbosa-De-Deus R., Dos Mares-Guia M.L., Nunes A.Z., Costa K.M., Junqueira R.G., Mayrink W., Genaro O., and Tavares C.A. Leishmania major-like antigen for specific and sensitive serodiagnosis of human and canine visceral leishmaniasis. Clin. Diagn. Lab. Immunol. 9 (2002) 1361-1366
7. Barral A., Barral-Netto M., Yong E.C., Brownell C.E., Twardzik D.R., and Reed S.G. Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 3442-3446
8. Belosevic M., Finbloom D.S., Van Der Meide P.H., Slayter M.V., and Nacy C.A. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143 (1989) 266-274
9. Calvopina M., Armijos R.X., Marco J.D., Uezato H., Kato H., Gomez E.A., Korenaga M., Barroso P.A., Mimori T., Cooper P.J., Nonaka S., and Hashiguchi Y. Leishmania isoenzyme polymorphisms in Ecuador: relationships with geographic distribution and clinical presentation. BMC Infect. Dis. 6 (2006) 139
10. da Silva R., and Sacks D.L. Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation. Infect. Immun. 55 (1987) 2802-2806
11. Da-Cruz A.M., Filgueiras D.V., Coutinho Z., Mayrink W., Grimaldi Jr. G., de Luca P.M., Mendonca S.C., and Coutinho S.G. Atypical mucocutaneous leishmaniasis caused by Leishmania braziliensis in an acquired immunodeficiency syndrome patient: T-cell responses and remission of lesions associated with antigen immunotherapy. Mem. Inst. Oswaldo Cruz 94 (1999) 537-542
12. Evans D. Special Programme for Research and Training in Tropical Diseases (1989), UNDP/World Bank/WHO, Geneva, Switzerland
13. Gomes R.F., Macedo A.M., Pena S.D., and Melo M.N. Leishmania (Viannia) braziliensis: genetic relationships between strains isolated from different areas of Brazil as revealed by DNA fingerprinting and RAPD. Exp. Parasitol. 80 (1995) 681-687
14. Hashiguchi Y., Gomez E.A., de C., Mimori V., Kawabata T., Furuya M., Nonaka M., Takaoka S., Alexander H., and Quizhpe J.B.A.M. Andean leishmaniasis in Ecuador caused by infection with Leishmania mexicana and L. major-like parasites. Am. J. Trop. Med. Hyg. 44 (1991) 205-217
15. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., and Locksley R.M. Reciprocal expression of interferon gamma or IL4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169 (1989) 59-72
16. + Lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7011-7016
17. Ishikawa E.A., Silveira F.T., Magalhaes A.L., Guerra junior R.B., Melo M.N., Gomes R., Silveira T.G., and Shaw J.J. Genetic variation in populations of Leishmania species in Brazil. Trans. R. Soc. Trop. Med. Hyg. 96 Suppl 1 (2002) S111-S121
18. Jeffreys A.J., Wilson V., and Thein S.L. Individual-specific 'fingerprints' of human DNA. Nature 316 (1985) 76-79
19. Katakura K., Matsumot Y., Gomez A.L.E., Furuya M., and Hashiguchi Y. Molecular Karyotipe characterization of Leishmania panamensis, Leishmania mexicana and Leishmania major-like parasites: agents of cutaneous leishmanissis in Ecuador. Am. J. Trop. Med. Hyg. 48-5 (1993) 707-715
20. Lainson R., and Shaw J.J. Evolution, classification and geographical distribution. In: Peters W., and Killick-Kendrick R. (Eds). The Leishmaniasis in Biology and Medicine vol. 1 (1987), Academic Press, New York 1-120 cap.1
21. Lima H.C., DeKrey G.K., and Titus R.G. Resolution of an infection with Leishmania braziliensis confers complete protection to a subsequent challenge with Leishmania major in BALB/c mice. Mem. Inst. Oswaldo Cruz 94 (1999) 71-76
22. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
23. Macedo A.M., Melo M.N., Gomes R.F., and Pena S.D. DNA fingerprints: a tool for identification and determination of the relationships between species and strains of Leishmania. Mol. Biochem. Parasitol. 53 (1992) 63-70
24. Mayrink W., Costa C.A., Magalhaes P.A., Melo M.N., Dias M., Oliveira Lima A., Michalick M.S., and Williams P. A field trial of a vaccine against American dermal leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 73 (1979) 385-387
25. Mayrink W., Magalhaes P.A., Michalick M.S.M., Costa C.A., Oliveira Lima A., Melo M.N., Toledo V.P.C.P., Nascimento E., Dias M., Genaro O., Hermeto M.V., and Williams P. Immunotherapy as a treatment of American cutaneous leishmaniasis: preliminaty studies in Brazil. Parassitologia 34 (1992) 159-165
26. Mayrink W., Williams P., Magalhäes P.A., Melo M.N., Dias M., Oliveira Lima A., Michalick M.S.M., Ferreira Carvalho E., Barros G.C., Sessa P.A., and Alencar J.T.A. An experimental vaccine against american dermal leishmaniasis: experience in the state of Espírito Santo. Brazil. Ann. Trop. Med. Parasitol. 79 (1985) 259-269
27. Melo M.N., Williams P., Magalhães Rocha N.M., Babá E.H., Mayrink W., Michalick M.S.M., da Costa C.A., Dias M., and Magalhães P.A. The change of behavior of two straisn of Leishmania after cultivation in a defined medium. Mem. Inst. Oswaldo Cruz 82 (1987) 557-561
28. Mimori T., Bañuls A.L., Furuya M., Gomez Landires E.A., Katakura K., Tibayrenc M., and Hashiguchi Y. Zymodeme characterization of Leishmania species, with special reference to Leishmania (Leishmania) major-like, isolated from Ecuador. Research Report Series Kochi 8 (2007) 36-44
29. Mollinson D.J., and Coombs G.H. Interactions Leishmania metacyclics with macrophages. Int. J. Parasitol. 19 (1989) 647-656
30. Momen H., Grimaldi G., Pacheco R.S., Jaffe C.L., McMahon-Pratt D., and Marzochi M.C. Brazilian leishmania stocks phenotipically similar to Leishmania major. Am. J. Trop. Med. Hyg. 34 (1985) 1076-1084
31. Nascimento E., Mayrink W., Costa C.A., Michalick M.S.M., Melo M.N., Barros G.C., Dias M., Antunes C.M.F., Lima M.S., Taboada D.C., and Liu T.Y. Vaccination of humans against cutaneous leishmaniasis: cellular and humoral immune responses. Infect. Immun. 58 (1990) 2198-2203
32. Nei M., and Li W.H. Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 5269-5273
33. Oliveira M.A., Santiago H.C., Lisboa C.R., Ceravollo I.P., Trinchieri G., Gazzinelli R.T., and Vieira L.Q. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis. Exp. Parasitol. 95 (2000) 96-105
34. Oliveira R.P., Macedo A.M., Chiari E., and Pena S.D. An alternative approach to evaluating the intraspecific genetic variability of parasites. Parasitol. Today 13 (1997) 196-200
35. Pena S.D., Macedo A.M., Gontijo N.F., Medeiros A.M., and Ribeiro J.C. DNA bioprints: simple nonisotopic DNA fingerprints with biotinylated probes. Electrophoresis 12 (1991) 146-152
36. Pena S.D.J., and Nunes A.C. DNA-POP and DNA-PATTER, two simple computer programs for population studies and paternity analysis with DNA fingerprintings. Fingeprintings News 2 (1990) 7-8
37. Pessôa S., and Martins B.A.V. Parasitologia Médica. 11 Ed. (1982), Guanabara Koogan, Rio de Janeiro
38. Sadick M.D., Heinzel F.P., Holaday B.J., Pu R.T., Dawkins R.S., and Locksley R.M. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. Med. 171 (1990) 115-127
39. Sambrook J., Fritch E.F., and Maniatis T. Molecular Cloning: A laboratory Manual. 2 Ed. (1989), Cold Spring Harbor Laboratory Press
40. Santos F.R., Pena S.D., and Epplen J.T. Genetic and population study of a Y-linked tetranucleotide repeat DNA polymorphism with a simple non-isotopic technique. Hum. Genet. 90 (1993) 655-656
41. Scott P. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147 (1991) 3149-3155
42. Shaw J.J. Taxonomy of the genus Leishmania: present and future trends and their implications. Mem. Inst. Oswaldo Cruz 89 (1994) 471-478
43. Shaw J.J. New World Leishmaniasis: The Ecology of Leishmaniasis and the diversity of leishmanial species in Central and South America. In: Farrel J.P. (Ed). World Class, Parasites, Leishmania vol. 4 (2002), Kluwer Acad. Publication, Boston 11-29
44. Soong L., Xu J.C., Grewal I.S., Kima P., Sun J., Longley B.J., Ruddle N.H., McMahon-Pratt D., and Flavell R.A. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4 (1996) 263-273
45. Spath G.F., and Beverley S.M. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp. Parasitol. 99 (2001) 97-103
46. Spath G.F., Epstein L., Leader B., Singer S.M., Avila H.A., Turco S.J., and Beverley S.M. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 9258-9263
47. Turco S.J., Spath G.F., and Beverley S.M. Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends Parasitol. 17 (2001) 223-226
48. Vieira L.Q., Goldschmidt M., Nashleanas M., Pfeffer K., Mak T., and Scott P. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157 (1996) 827-835
49. Volf P., and Myskova J. Sand flies and Leishmania: specific versus permissive vectors. Trends Parasitol. 23 (2007) 91-92
50. Volpini A.C., de A.P., and Romanha V.A.J. Attempt to differentiate Leishmania (Leishmania) amazonensis, L. (L.) chagasi Leishmania (Viannia) braziliensis and L. (V.) guyanensis using the SSR-PCR technique. Parasitol. Res. 87 (2001) 1056-1059
51. Yamasaki H., Agatsuma T., Pavon B., Moran M., Furuya M., and Aoki T. Leishmania major-like parasite, a pathogenic agent of cutaneous leishmaniasis in Paraguay. Am. J. Trop. Med. Hyg. 51 (1994) 749-757
52. Zietkiewicz E., Rafalski A., and Labuda D. Genome fingerprinting by simple sequence repeat (SSR)-anchored polymerase chain reaction amplification. Genomics 20 (1994) 176-183